An endogenous peptide marker differentiates SOD1 stability and facilitates pharmacodynamic monitoring in SOD1 amyotrophic lateral sclerosis

Overview of attention for article published in JCI Insight, May 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (82nd percentile)
Good Attention Score compared to outputs of the same age and source (70th percentile)

Mentioned by

news: 1 news outlet

twitter: 4 X users

Readers on

mendeley: 48 Mendeley

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 41,716 followers.

An endogenous peptide marker differentiates SOD1 stability and facilitates pharmacodynamic monitoring in SOD1 amyotrophic lateral sclerosis. https://t.co/YVZmSdcUqr

Biomarker differentiates SOD1 stability and facilitates pharmacodynamic monitoring in SOD1-driven ALS https://t.co/3X0WgLA5jN @Ludwig_Cancer @UCSDHealth #neuroscience #ALS

An endogenous peptide marker differentiates SOD1 stability and facilitates pharmacodynamic monitoring in SOD1 amyotrophic lateral sclerosis. https://t.co/Uh1kGsPsMm

Researchers introduce a strategy to monitor target engagement in #clinicaltrials of SOD1-targeted therapies - a key step in evaluating potential therapies for #SOD1 #ALS https://t.co/l2gE6t9rEL @JCI_insight https://t.co/AS5R67OBsu

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.